| Samantha Keener Blanchet, PHARMD | |
|
1430 Quintard Ave, Anniston, AL 36201-3845 | |
| (256) 237-0759 | |
| (256) 237-3023 |
| Full Name | Samantha Keener Blanchet |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1430 Quintard Ave, Anniston, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295859338 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 15300 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Samantha Keener Blanchet, PHARMD 1430 Quintard Ave, Anniston, AL 36201-3845 Ph: (256) 237-0759 | Samantha Keener Blanchet, PHARMD 1430 Quintard Ave, Anniston, AL 36201-3845 Ph: (256) 237-0759 |
News Archive
A new study led by Massachusetts General Hospital investigators finds that heart failure patients who underwent bariatric surgery to treat morbid obesity had a significant reduction in the incidence of heart failure exacerbation - a dangerous, sudden worsening of symptoms - in the two years following surgery.
In a recent bioRxiv* preprint paper, researchers isolated anti-RBD nanobodies from llamas and "nanomice" (they engineered to produce VHHs cloned from alpacas, dromedaries and camels).
Harvard Bioscience, Inc., a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, has filed two major patents in the field of regenerative medicine, the first covering 61 claims for its stem cell therapy injectors and the second for 338 claims for bioreactors for organ growth.
How changes in the weather affect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been the topic of several studies. The preoccupation of researchers with this aspect of the coronavirus disease 2019 (COVID-19) pandemic follows from observations that the flu virus and other coronaviruses follow seasonal patterns. Understanding how SARS-CoV-2's transmissibility is affected by seasonal changes can thus help us to develop more informed preventative measures against its spread.
Cyclacel Pharmaceuticals, Inc. announced today that updated Phase 2 clinical trial results of sapacitabine for the treatment of myelodysplastic syndromes (MDS) will be presented at a poster presentation during the 52nd Annual Meeting of the American Society of Hematology (ASH) in Orlando, on Saturday, December 4, 2010.
› Verified 8 days ago
Dr. David Adam Kelly, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1401 S Quintard Ave, Anniston, AL 36201 Phone: 256-237-0759 Fax: 256-237-3023 | |
Dr. Molly Victoria Gaines, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1404 Golden Springs Rd, Anniston, AL 36207 Phone: 256-832-0046 Fax: 256-832-0335 | |
Mr. Patrick Lane Knight, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Noble St, Anniston, AL 36201 Phone: 256-236-2271 Fax: 256-236-1859 | |
Mr. Maurice D Grider, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1311 Lakeshore Dr, Anniston, AL 36207 Phone: 256-238-0344 | |
Nancy Schewanick, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Noble St, Anniston, AL 36201 Phone: 256-236-2271 Fax: 256-236-1859 | |
Marcus Compton, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1801 Quintard Ave, Anniston, AL 36201 Phone: 256-831-6116 | |
Michelle Friday, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2413 Highway 431 North, Anniston, AL 36206 Phone: 256-820-6901 |